US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

248.72

-0.9300-0.37%

Post-market: 250.001.28+0.51%19:59 EDT

Volume:344.92K

Turnover:86.47M

Market Cap:565.71M

PE:- -

High:259.39

Open:256.76

Low:244.53

Close:249.65

52wk High:341.93

52wk Low:95.98

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.06

T/O Rate:15.16%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Jianyou Pharmaceutical's Subsidiary Gains US FDA Approval for Vitamin B1 Injection Product

Incyte, Mirum's Treatment of Rare Genetic Ossification Condition Approved by US FDA

MT Newswires Live

Amvis to Launch AI-Focused Subsidiary AIZIA to Boost Healthcare Productivity

Austco Director Increases Shareholding After Performance Rights Vesting

Healthcare & Medical Investment Corp Secures Social Loan for 800 Million Yen Refinancing

Austco Healthcare Issues 2.7 Million New Shares on Conversion of Unquoted Securities

DKSH Expands Grünenthal Pain Management Partnership Across Eight Asia-Pacific Markets

Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Holdings (SENS)

Lupin Wins U.S. FDA Tentative Nod for Novel Apixaban Oral Suspension

Zydus Lifesciences' US Office FDA Inspection Ends With No Observations

MT Newswires Live

EBR Systems Says US FDA Completes Inspection of New California Facility; Shares Up 4%

MT Newswires Live

Wall Street Analysts Are Bullish on Top Healthcare Picks

EBR Systems advances FDA approval process for new WiSE manufacturing site

Analyst Reiterates Buy on Nektar as Legal Overhang Clears, REZPEG Outlook Strengthens and $178 Price Target Remains Unchanged

Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE)

Supreme Court Clears Independent Forensic Audit of Fortis Healthcare

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roivant Sciences (ROIV) and Johnson & Johnson (JNJ)

Aster DM Quality Care Secures Shareholder Nod on Postal Ballot Resolutions

Aster DM Quality Care Closes Trading Window Ahead of September Quarter Results

LifeSci Capital Remains a Buy on Pyxis Oncology (PYXS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/LABU/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":248.72,"timestamp":1790971200000,"preClose":249.65,"halted":0,"volume":344920,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"delay":0,"changeRate":-0.003725215301422018,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Closed","change":-0.93,"latestTime":"10-02 16:00:00 EDT","open":256.755,"high":259.39,"low":244.53,"amount":86471147.3688,"amplitude":0.059523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":248.875,"aum":566062383.8,"dividendRate":0.003633,"bidAskSpread":0.003777,"preHourTrading":{"tag":"盘前","latestPrice":256,"preClose":249.65,"latestTime":"09:27 EDT","volume":5553,"amount":1438964.4383999999,"timestamp":1790947678782,"change":6.35,"changeRate":0.025436,"amplitude":0.043381},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"volumeRatio":1.05546,"impliedVol":0.9378,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.05546,"shares":2274486,"dividePrice":0.9037,"high":259.39,"amplitude":0.059523,"preClose":249.65,"low":244.53,"week52Low":95.98,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":248.72,"eps":0,"divideRate":0.003633,"volume":344920,"delay":0,"ttmEps":0,"open":256.755,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":252.47,"twentyDayClose":305.86,"sixtyDayClose":324.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185130345","title":"Jianyou Pharmaceutical's Subsidiary Gains US FDA Approval for Vitamin B1 Injection Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1185130345","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185130345?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:40","pubTimestamp":1790584825,"startTime":"0","endTime":"0","summary":"Jianyou Pharmaceutical (603707.SH) has announced that its subsidiary, Hong Kong Jianyou Industrial Co., Ltd. (\"Hong Kong Jianyou\"), recently received an ANDA approval notice (ANDA number: 213131)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0186","BK0046","BK4585","LABU","603707","BK0239","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670428776","title":"Incyte, Mirum's Treatment of Rare Genetic Ossification Condition Approved by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2670428776","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670428776?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:25","pubTimestamp":1790583903,"startTime":"0","endTime":"0","summary":"Incyte  and Mirum Pharmaceuticals'  Atebrioz tablet has been approved by the US Food and Drug Administration to treat adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva, the companies said Friday.The disease is a very rare genetic disease in which bone forms in muscles, tendons, ligaments and other soft tissues, progressively restricting movements. The drug reduces the volume of new ossification, they said.The drug, developed by Incyte and licensed to Mirum Pharmaceuticals, is expected to be available in the US in November, the companies said.The FDA also granted Incyte a rare pediatric disease priority review voucher which can be used in a later application, the companies said.The European Union is also now reviewing a marketing authorization application for the drug, the companies said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4139","IDNA","INCY","BK4588","BK4550","MIRM","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670287464","title":"Amvis to Launch AI-Focused Subsidiary AIZIA to Boost Healthcare Productivity","url":"https://stock-news.laohu8.com/highlight/detail?id=2670287464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670287464?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:10","pubTimestamp":1790583012,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Amvis Holdings.Inc. ( ($JP:7071) ). Amvis Holdings, Inc. has resolved to establish AIZIA, Inc. as a wholly owne...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amvis-to-launch-ai-focused-subsidiary-aizia-to-boost-healthcare-productivity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amvis-to-launch-ai-focused-subsidiary-aizia-to-boost-healthcare-productivity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","QTOC","ARTY","AIPO","BK4588","XBI","AGIX","XLV","BK4137","LU0029874061.USD","VTHR","BK4581","BK4585","HCSG","CHAT","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670284100","title":"Austco Director Increases Shareholding After Performance Rights Vesting","url":"https://stock-news.laohu8.com/highlight/detail?id=2670284100","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670284100?lang=en_us&edition=fundamental","pubTime":"2026-09-28 15:01","pubTimestamp":1790578860,"startTime":"0","endTime":"0","summary":"Austco Healthcare Limited ( ($AU:AHC) ) has issued an announcement. Austco Healthcare Limited has disclosed a change in the holdings of director Cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/austco-director-increases-shareholding-after-performance-rights-vesting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/austco-director-increases-shareholding-after-performance-rights-vesting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","XLV","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670831284","title":"Healthcare & Medical Investment Corp Secures Social Loan for 800 Million Yen Refinancing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670831284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670831284?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:55","pubTimestamp":1790578530,"startTime":"0","endTime":"0","summary":"An announcement from Healthcare & Medical Investment Corp ( ($JP:3455) ) is now available. Healthcare & Medical Investment Corporation has arranged...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthcare-medical-investment-corp-secures-social-loan-for-800-million-yen-refinancing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthcare-medical-investment-corp-secures-social-loan-for-800-million-yen-refinancing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","XBI","BK4585","BK4588","HCSG","BK4137","BK4581","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670602281","title":"Austco Healthcare Issues 2.7 Million New Shares on Conversion of Unquoted Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2670602281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670602281?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:37","pubTimestamp":1790577470,"startTime":"0","endTime":"0","summary":"Austco Healthcare Limited ( ($AU:AHC) ) has shared an announcement. Austco Healthcare Limited has notified the market that 2,730,877 ordinary fully...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-issues-2-7-million-new-shares-on-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-issues-2-7-million-new-shares-on-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","HCSG","BK4137","BK4585","XBI","BK4588","LABU","XLV","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670286106","title":"DKSH Expands Grünenthal Pain Management Partnership Across Eight Asia-Pacific Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2670286106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670286106?lang=en_us&edition=fundamental","pubTime":"2026-09-28 13:33","pubTimestamp":1790573585,"startTime":"0","endTime":"0","summary":"DKSH Holding AG ( ($CH:DKSH) ) has provided an announcement. DKSH’s Healthcare unit has expanded its collaboration with Grünenthal, a global leader...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dksh-expands-grunenthal-pain-management-partnership-across-eight-asia-pacific-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dksh-expands-grunenthal-pain-management-partnership-across-eight-asia-pacific-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4588","XLV","LABU","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670165285","title":"Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Holdings (SENS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670165285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670165285?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:40","pubTimestamp":1790570421,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Hol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-celldex-cldx-nanobiotix-nbtx-and-senseonics-holdings-sens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-celldex-cldx-nanobiotix-nbtx-and-senseonics-holdings-sens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4139","BK4581","XBI","BK4585","LU0029874061.USD","LU0128526141.USD","BK4082","BK4588","BK4137","NBTX","LABU","CLDX","HCSG","SENS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670285199","title":"Lupin Wins U.S. FDA Tentative Nod for Novel Apixaban Oral Suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2670285199","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670285199?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:34","pubTimestamp":1790570051,"startTime":"0","endTime":"0","summary":"Lupin Limited ( ($IN:LUPIN) ) has issued an announcement. Lupin Limited has secured tentative approval from the U.S. FDA for its Apixaban Oral Susp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lupin-wins-u-s-fda-tentative-nod-for-novel-apixaban-oral-suspension?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lupin-wins-u-s-fda-tentative-nod-for-novel-apixaban-oral-suspension?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670229288","title":"Zydus Lifesciences' US Office FDA Inspection Ends With No Observations","url":"https://stock-news.laohu8.com/highlight/detail?id=2670229288","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670229288?lang=en_us&edition=fundamental","pubTime":"2026-09-28 11:07","pubTimestamp":1790564876,"startTime":"0","endTime":"0","summary":"Zydus Lifesciences (BOM:532321, NSE:ZYDUSLIFE) said a U.S. Food and Drug Administration inspection of its pharmacovigilance and post-marketing surveillance system at its New Jersey office concluded with no observations, according to a Saturday exchange filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670055400","title":"EBR Systems Says US FDA Completes Inspection of New California Facility; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670055400","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670055400?lang=en_us&edition=fundamental","pubTime":"2026-09-28 10:22","pubTimestamp":1790562130,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration  has completed its inspection of the company's new California manufacturing facility, according to a Monday filing with the Australian bourse.The inspection was carried out in relation to the company's pre-market approval supplement to add the facility as a manufacturing site for the WiSE System, its lead-less left ventricular endocardial pacing device designed for cardiac resynchronization therapy in heart failure patients, the filing said.The US FDA investigator issued a Form FDA 483 listing two routine observations, which the company has \"promised to correct.\"Facility approval is anticipated by year-end, per the filing.EBR Systems shares rose 4% in morning trade Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK4585","BK4588","EBR.AU","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402934","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402934?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:10","pubTimestamp":1790554207,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mesoblast Limited (MEOBF) and Cogstate Ltd (COGZF) w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-353?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-353?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","BK4137","COGZF","LU0029874061.USD","BK4588","BK4581","MEOBF","BK4585","BK4139","LU0128526141.USD","HCSG","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","EES","PSCH","FRTY","GDOC","IDNA","MRNX","BMED","IYH","XLVX","BK4588","LABU","BBP","TECB","GNMX","TBXU","SYNB","NVIB","IBB","LFSC","IEIH","BK4585","MRNY","RSPH","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670995404","title":"Analyst Reiterates Buy on Nektar as Legal Overhang Clears, REZPEG Outlook Strengthens and $178 Price Target Remains Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2670995404","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670995404?lang=en_us&edition=fundamental","pubTime":"2026-09-28 06:45","pubTimestamp":1790549119,"startTime":"0","endTime":"0","summary":"Nektar Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst on September 25. Analyst Julian Harrison from BTIG reite...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-nektar-as-legal-overhang-clears-rezpeg-outlook-strengthens-and-178-price-target-remains-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-nektar-as-legal-overhang-clears-rezpeg-outlook-strengthens-and-178-price-target-remains-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4585","BK4581","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670740486","title":"Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670740486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670740486?lang=en_us&edition=fundamental","pubTime":"2026-09-28 05:30","pubTimestamp":1790544629,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE). Oncolyti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oncolytics-biotech-oncy-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oncolytics-biotech-oncy-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYRE","BK4588","BK4137","LABU","BK4581","LU0128526141.USD","ONCY","LU0029874061.USD","BK4585","LFSC","XLV","HCSG","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670240875","title":"Supreme Court Clears Independent Forensic Audit of Fortis Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2670240875","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670240875?lang=en_us&edition=fundamental","pubTime":"2026-09-27 15:42","pubTimestamp":1790494962,"startTime":"0","endTime":"0","summary":"Fortis Healthcare Ltd. ( ($IN:FORTIS) ) has issued an update. Fortis Healthcare Ltd. said the Supreme Court of India has disposed of its Special Le...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/supreme-court-clears-independent-forensic-audit-of-fortis-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/supreme-court-clears-independent-forensic-audit-of-fortis-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","LU0128526141.USD","BK4585","XLV","BK4588","LABU","BK4581","HCSG","MNDmain","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670889472","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roivant Sciences (ROIV) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670889472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670889472?lang=en_us&edition=fundamental","pubTime":"2026-09-27 01:00","pubTimestamp":1790442018,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roivant Sciences (ROIV) and Johnson & Johnson (JNJ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roivant-sciences-roiv-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roivant-sciences-roiv-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","BK4550","LU2756315664.SGD","JNJ","FHLC","BK4585","IYH","LU2403377893.USD","ROIV","LU0124676726.USD","LU0943347566.SGD","LABU","BK4588","FTXH","LU0234572021.USD","HCSG","BK4007","BK4581","GDOC","MEDX","LU0058720904.USD","LU0912757837.SGD","BK4532","LU1430594728.SGD","XLV","LU0426417589.USD","XBI","IHE","LU1674673428.USD","JDOC","LU1061106388.HKD","IXJ","TRUH","LU0738911758.USD","LU0069063385.USD","LU1629891620.HKD","LU0289739343.SGD","PTH","RXL","LU0053666078.USD","LU1929549753.HKD","PJP","LU0545562505.USD","VHT","LU2430703095.HKD","IE00BDGV0183.EUR","BMED","LU1280957306.USD","LU2750360997.AUD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670474927","title":"Aster DM Quality Care Secures Shareholder Nod on Postal Ballot Resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2670474927","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670474927?lang=en_us&edition=fundamental","pubTime":"2026-09-26 23:03","pubTimestamp":1790435008,"startTime":"0","endTime":"0","summary":"The latest update is out from Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ). Aster DM Quality Care Limited, formerly Aster DM Healthcare Limited, is a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-secures-shareholder-nod-on-postal-ballot-resolutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-secures-shareholder-nod-on-postal-ballot-resolutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","XBI","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670942474","title":"Aster DM Quality Care Closes Trading Window Ahead of September Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2670942474","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670942474?lang=en_us&edition=fundamental","pubTime":"2026-09-26 23:03","pubTimestamp":1790434991,"startTime":"0","endTime":"0","summary":"Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ) has provided an update. Aster DM Quality Care Limited has announced the closure of its trading window fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-closes-trading-window-ahead-of-september-quarter-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-closes-trading-window-ahead-of-september-quarter-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","XLV","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670474592","title":"LifeSci Capital Remains a Buy on Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670474592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670474592?lang=en_us&edition=fundamental","pubTime":"2026-09-26 22:35","pubTimestamp":1790433318,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Pyxis Oncology today and set a price target of $8.00. Slutsky covers the Healthcare ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","XBI","BK4588","PYXS","XLV","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":10,"totalSize":395,"code":"91000000","status":"200"}]}}